These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38963028)

  • 21. [Early detection by urinary proteome analysis : A new concept in patient management of diabetic nephropathy].
    Beige J; Drube J; von der Leyen H; Pape L; Rupprecht H
    Internist (Berl); 2020 Oct; 61(10):1094-1105. PubMed ID: 32897404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of biomarkers for early diagnosis of diabetic nephropathy disease using direct flow through mass spectrometry.
    Nilavan E; Sundar S; Shenbagamoorthy M; Narayanan H; Nandagopal B; Srinivasan R
    Diabetes Metab Syndr; 2020; 14(6):2073-2078. PubMed ID: 33125920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A more tubulocentric view of diabetic kidney disease.
    Zeni L; Norden AGW; Cancarini G; Unwin RJ
    J Nephrol; 2017 Dec; 30(6):701-717. PubMed ID: 28840540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic nephropathy in a sibling and albuminuria predict early GFR decline: a prospective cohort study.
    Gunzler D; Bleyer AJ; Thomas RL; O'Brien A; Russell GB; Sattar A; Iyengar SK; Thomas C; Sedor JR; Schelling JR
    BMC Nephrol; 2013 Jun; 14():124. PubMed ID: 23773264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers for Diabetic Nephropathy with a Focus on Kidney Injury Molecule-1 (KIM-1).
    Khonsha F; Valilo M; Nejabati HR; Rahmati-Yamchi M; Mota A
    Curr Diabetes Rev; 2024; 20(1):e280323215071. PubMed ID: 36994981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Network pharmacology combined with metabolomics to study the mechanism of Shenyan Kangfu Tablets in the treatment of diabetic nephropathy.
    Wang X; He Q; Chen Q; Xue B; Wang J; Wang T; Liu H; Chen X
    J Ethnopharmacol; 2021 Apr; 270():113817. PubMed ID: 33444720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?
    Mu X; Yang M; Ling P; Wu A; Zhou H; Jiang J
    Diabetes Metab Syndr Obes; 2022; 15():247-256. PubMed ID: 35125878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
    Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
    J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased lipoxygenase and decreased cytochrome P450s metabolites correlated with the incidence of diabetic nephropathy: Potential role of eicosanoids from metabolomics in type 2 diabetic patients.
    Peng L; Sun B; Liu Y; Huang J; Chen G; Zhang X; Chen C; Wang D; Wang G
    Clin Exp Pharmacol Physiol; 2021 May; 48(5):679-685. PubMed ID: 33605471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem cell-derived and circulating exosomal microRNAs as new potential tools for diabetic nephropathy management.
    Peng L; Chen Y; Shi S; Wen H
    Stem Cell Res Ther; 2022 Jan; 13(1):25. PubMed ID: 35073973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus.
    Shoukry A; Bdeer Sel-A; El-Sokkary RH
    Mol Cell Biochem; 2015 Oct; 408(1-2):25-35. PubMed ID: 26104579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic profiling reveals new serum biomarkers for differentiating diabetic nephropathy.
    Hirayama A; Nakashima E; Sugimoto M; Akiyama S; Sato W; Maruyama S; Matsuo S; Tomita M; Yuzawa Y; Soga T
    Anal Bioanal Chem; 2012 Dec; 404(10):3101-9. PubMed ID: 23052862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential Role of N-Cadherin in Diagnosis and Prognosis of Diabetic Nephropathy.
    Ali H; Abu-Farha M; Hammad MM; Devarajan S; Bahbahani Y; Al-Khairi I; Cherian P; Alsairafi Z; Vijayan V; Al-Mulla F; Attar AA; Abubaker J
    Front Endocrinol (Lausanne); 2022; 13():882700. PubMed ID: 35712247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diabetic Nephropathy - possibilities of early laboratory diagnostics and course prediction (review of literature).
    Popykhova EB; Ivanov AN; Stepanova TV; Lagutina DD; Savkina AA
    Klin Lab Diagn; 2021 Oct; 66(10):593-602. PubMed ID: 34665945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Novel biomarkers for diabetic nephropathy].
    Araki S
    Rinsho Byori; 2014 Feb; 62(2):171-9. PubMed ID: 24800493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy.
    Gluhovschi C; Gluhovschi G; Petrica L; Timar R; Velciov S; Ionita I; Kaycsa A; Timar B
    J Diabetes Res; 2016; 2016():4626125. PubMed ID: 27413755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-Hydroxyhexanoic Acid Predicts Early Renal Functional Decline in Type 2 Diabetes Patients with Microalbuminuria.
    Tang X; You J; Liu D; Xia M; He L; Liu H
    Kidney Blood Press Res; 2019; 44(2):245-263. PubMed ID: 31071709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered metabolic profiles and targets relevant to the protective effect of acteoside on diabetic nephropathy in db/db mice based on metabolomics and network pharmacology studies.
    Gao W; Gao S; Zhang Y; Wang M; Liu Y; Li T; Gao C; Zhou Y; Bian B; Wang H; Wei X; Sato T; Si N; Zhao W; Zhao H
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117073. PubMed ID: 37619856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights into predicting diabetic nephropathy using urinary biomarkers.
    Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L
    Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases.
    Wang G; Ouyang J; Li S; Wang H; Lian B; Liu Z; Xie L
    J Transl Med; 2019 Aug; 17(1):264. PubMed ID: 31409386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.